Evaluation of safety and efficacy of levadex™ (MAP0004) in treating acute menstrual migraine

被引：0
|
作者：
Kori, S. [1 ]
Schreiber, C. [2 ]
Lucas, S. [3 ]
Borland, S. [4 ]
Wang, M. [4 ]
Hu, B. [4 ]
Brandes, J. [5 ]
机构：
[1] MAP Pharmaceut, Clin, Mountain View, CA USA
[2] Headache Care Ctr, Springfield, MO USA
[3] Univ Washington, Med Ctr, Seattle, WA 98195 USA
[4] MAP Pharmaceut, Mountain View, CA USA
[5] Nashville Neurosci Grp, Nashville, TN USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2010年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
465
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [1] Evaluation of Safety and Efficacy of MAP0004 in Treating Acute Menstrual Migraine
    Schreiber, Curt
    Kori, Shashidhar H.
    Lucas, Sylvia
    Borland, Scott W.
    Wang, Min
    Hu, Bin
    Brandes, Jan
    NEUROLOGY, 2010, 74 (09) : A396 - A396
  • [2] Evaluation of efficacy and safety of levadex™ (MAP0004) in reversing central sensitization and treating migraine in established allodynic patients
    Kori, S.
    Tepper, S.
    Borland, S.
    Wang, M.
    Hu, B.
    Silberstein, S.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S116 - S117
  • [3] Efficacy of MAP0004 in treating severe migraine
    Kori, S.
    Connors, E.
    Zhou, J.
    Lu, B.
    Borland, S.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [4] Efficacy of MAP0004 in treating severe migraine
    S Kori
    E Connors
    J Zhou
    B Lu
    S Borland
    The Journal of Headache and Pain, 2013, 14
  • [5] Efficacy of MAP0004 in Treating Severe Migraine Pain
    Kori, Shashidhar
    Connors, Emilee
    Zhou, Jay
    Lu, Biao
    Borland, Scott
    NEUROLOGY, 2013, 80
  • [6] Efficacy evaluation of LEVADEX™ (previously MAP0004) in treating resistant migraine including migraine with allodynia, morning migraine, disabling migraine and migraine treated late in its cycle
    Tepper, S. J.
    Kori, S. H.
    Mathew, N. T.
    Saper, J. R.
    Winner, P. K.
    Freitag, F. G.
    Borland, S. W.
    Wang, M.
    Hu, B.
    Silberstein, S. D.
    CEPHALALGIA, 2009, 29 (12) : 1357 - 1358
  • [7] Evaluation of Efficacy and Safety of MAP0004 in Reversing Central Sensitization and Treating Migraine in Established Allodynic Patients
    Tepper, Stewart J.
    Kori, Shashidhar H.
    Borland, Scott W.
    Wang, Min
    Hu, Bin
    Silberstein, Stephen
    NEUROLOGY, 2010, 74 (09) : A321 - A321
  • [8] Efficacy evaluation of LEVADEX™ (previously MAP0004) in treating a broad spectrum of acute migraine attacks including patients using triptans and patients not using triptans
    Winner, P. K.
    Kori, S. H.
    Freitag, F. G.
    Goldstein, J.
    Borland, S. W.
    Wang, M.
    Hu, B.
    Brandes, J. L.
    CEPHALALGIA, 2009, 29 (12) : 1358 - 1358
  • [9] Efficacy and tolerability of MAP0004, featuring a movel delivery system, in treating acute migraine
    Shrewsbury, Stephen
    Kori, Shashidhar
    Smith, Timothy
    Spierings, Egilius
    NEUROLOGY, 2008, 70 (11) : A426 - A426
  • [10] Efficacy and tolerability of MAP0004, a novel orally inhaled therapy, in treating acute migraine
    Silberstein, S. D.
    Kori, S. H.
    Tepper, S. J.
    Borland, S. W.
    Wang, M.
    Reppine, A. E.
    Armer, T. A.
    Dodick, D. W.
    CEPHALALGIA, 2009, 29 : 12 - 13
12345